Literature DB >> 15833832

SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.

Alfonso Cristaudo1, Rudy Foddis, Agnese Vivaldi, Rodolfo Buselli, Vittorio Gattini, Giovanni Guglielmi, Francesca Cosentino, Franco Ottenga, Eugenio Ciancia, Roberta Libener, Rosangela Filiberti, Monica Neri, Piergiacomo Betta, Mauro Tognon, Luciano Mutti, Riccardo Puntoni.   

Abstract

We conducted a case-control study on asbestos exposure and presence of SV40 in tumor samples of malignant mesotheliomas (MMs) and bladder urotheliomas (BUs). PCR analysis revealed the presence of SV40 DNA (SV40+) in eight (42.1%) MMs and 6 (33.3%) BUs. The odds ratio for MM Asb- and SV40+ was 0.4 [95% confidence interval (95% CI), 0.03-4.0], for Asb+ and SV40- was 3.6 (95% CI, 0.6-21.0), and for Asb+ and SV40+ was 12.6 (95% CI, 1.2-133.9). Our results suggest that SV40 increases the risk of MM among individuals exposed to asbestos.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833832     DOI: 10.1158/0008-5472.CAN-04-2219

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  Current issues in malignant pleural mesothelioma evaluation and management.

Authors:  Jing Ai; James P Stevenson
Journal:  Oncologist       Date:  2014-07-24

3.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.

Authors:  Barbara Kroczynska; Rochelle Cutrone; Maurizio Bocchetta; Haining Yang; Amira G Elmishad; Pamela Vacek; Maria Ramos-Nino; Brooke T Mossman; Harvey I Pass; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

4.  Presence of simian virus 40 DNA sequences in egyptian patients with lymphoproliferative disorders.

Authors:  Waleed S Mohamed; Mohamed A Samra; Mohamed A Fawzy
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

5.  In vitro and in vivo characterization of highly purified human mesothelioma derived cells.

Authors:  Alice Melotti; Antonio Daga; Daniela Marubbi; Annalisa Zunino; Luciano Mutti; Giorgio Corte
Journal:  BMC Cancer       Date:  2010-02-22       Impact factor: 4.430

6.  High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.

Authors:  Elisa Mazzoni; Alfredo Corallini; Alfonso Cristaudo; Angelo Taronna; Gianfranco Tassi; Marco Manfrini; Manola Comar; Massimo Bovenzi; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Giovanni Rezza; Giuseppe Barbanti-Brodano; Fernanda Martini; Mauro G Tognon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

Review 7.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

8.  SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.

Authors:  Thomas Henzi; Walter-Vincent Blum; Martine Pfefferli; Tadeusz J Kawecki; Valerie Salicio; Beat Schwaller
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

Review 9.  Polyomaviruses of nonhuman primates: implications for research.

Authors:  Meredith A Simon
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

10.  No detection of simian virus 40 in malignant mesothelioma in Korea.

Authors:  Minseob Eom; Jamshid Abdul-Ghafar; Sun-Mi Park; Joung Ho Han; Soon Won Hong; Kun Young Kwon; Eun Suk Ko; Lucia Kim; Wan Seop Kim; Seung Yeon Ha; Kyo Young Lee; Chang Hun Lee; Hye Kyoung Yoon; Yoo Duk Choi; Myoung Ja Chung; Soon-Hee Jung
Journal:  Korean J Pathol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.